Skip to content

WISE-2B Brain Study (Weight Loss Intervention Surgical Effects on Brain Function)

Obesity and Type 2 Diabetes: Bariatric Surgery Effects on Brain Function -Part 2 (WISE-2B Brain Study)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06861790
Enrollment
120
Registered
2025-03-06
Start date
2025-11-10
Completion date
2027-12-01
Last updated
2026-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes, Weight Loss

Keywords

Weight loss and brain function, Effects of bariatric surgery on brain function, Reduced glucose insulin changes and brain function, tVNS intervention post-surgery

Brief summary

The goal of the study to understand the effects of weight loss and improvements in diabetes following bariatric surgery on brain function and thinking. This study will also examine whether non-invasive transcutaneous vagal nerve stimulation (tVNS) intervention initiated 30 days post-surgery improves brain function and thinking. The study does NOT cover any costs associated with bariatric surgery.

Detailed description

There will be one group of study participants. The group will (independently of this research study) have weight loss surgery to help them with weight loss. All research participants in this group will be tested on thinking and memory processes at the start of the study, after 12 weeks, and again at 18 months. They will also undergo a non-invasive transcutaneous vagal nerve stimulation (tVNS) intervention days post-surgery, for 30 days at home with the device that is provided. The group will have an MRI Brain Scan at each time-point to study the changes in the structure and function of the brain tissue. Blood tests will be done to measure the sugar levels in the blood, and other proteins that may act as markers for disease.

Interventions

BEHAVIORALtVNS

Though we will be utilizing a tVNS (Transcutaneous Vegus Nerve Stimulation) device this study is not a device study. The device being used is being done so under its approved usage. The intervention utilizes a non-invasive process to stimulate the Vagus nerve using very small electrical currents. This intervention is completed daily for one month.

PROCEDUREComplete Vagotomy

Participants will not be receiving bariatric surgery as an intervention of this study. Instead, the study will enroll patients already planning on undergoing the surgery. The surgeon will utilize one of two surgical approaches which will be observed in this study.

PROCEDUREAnterior Vagotomy

Participants will not be receiving bariatric surgery as an intervention of this study. Instead, the study will enroll patients already planning on undergoing the surgery. The surgeon will utilize one of two surgical approaches which will be observed in this study.

Sponsors

University of Florida
Lead SponsorOTHER
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
OTHER
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
20 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Between age: 20-75 yrs, English speaking, Physically mobile * Body Mass Index (BMI) \>35 kg before surgery * Compatible of MRI Scanning * Willing to give a small blood sample * Capable of providing informed consent

Exclusion criteria

* Prior or current neurological disorder * Major psychiatric disturbance * Unstable medical conditions (cancer) * MRI contraindications (claustrophobia, metal implants, waist/torso circumference)

Design outcomes

Primary

MeasureTime frameDescription
Brain inflammation - MRS18 monthsUtilizing MRS the study seeks to understand changes in brain inflammation between the groups
Cognitive functioning - Global functioning score18 monthsUtilizing a battery of cognitive tests the study seeks to determine changes in cognitive functioning. This can be determined by computing the Global functioning score on the battery of measures.

Countries

United States

Contacts

CONTACTKeyanni J Johnson
kjjohnson@ufl.edu3522945618
CONTACTRonald Cohen, PhD
roncohen@ufl.edu352-295-5840
PRINCIPAL_INVESTIGATOREric Porges, PhD

University of Florida

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026